Bogart Wealth’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Other funds holding LGND
Bogart Wealth's LGND Position: Q3 2026 in Review
Bogart Wealth held its Ligand Pharmaceuticals (LGND) position steady in Q3 2026 at 18 shares worth $5.62K. The position accounts for ﹤0.01% of the portfolio, ranked #1198.
Bogart Wealth first reported a position in LGND in Q3 2022 and has held it in 9 quarters since. The position peaked at $5.69K in Q2 2026. 434 funds tracked by Wall St. Rank hold LGND as of Q3 2026.
- Bogart Wealth held 18 shares of Ligand Pharmaceuticals worth $5.62K as of Q3 2026.
- Bogart Wealth left its Ligand Pharmaceuticals share count unchanged in Q3 2026.
- Ligand Pharmaceuticals made up ﹤0.01% of Bogart Wealth's portfolio in Q3 2026, its #1198 holding.
- Bogart Wealth first reported a position in Ligand Pharmaceuticals in Q3 2022 and has held it in 9 quarters since.
- Bogart Wealth's Ligand Pharmaceuticals position peaked at $5.69K in Q2 2026.
- 434 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2026.
Based on Bogart Wealth's 13F filing for Q3 2026, filed 10 Nov 2026.